Moreover, the proportion of CD8+CD28- T cells, which were found to have the immune suppressive function, increased in the naive T (TN) cell and TCM subsets in CML patients compared with HIs. This evidence concerns the gene CD28 and chronic myelogenous leukemia, BCR-ABL1 positive.